ABP Pediatric Rheumatology common mistakes
ABP Pediatric Rheumatology · Understand the traps and how to avoid them.
Committing to a specific JIA subtype on the first visit based only on the joint count at that moment, without documenting the 6-week duration, systemic features, enthesitis, psoriasis, IBD, or RF status.
Subtype definitions hinge on time-dependent features: oligoarthritis persistent versus extended is determined at 6 months, and systemic JIA requires the characteristic fever/rash rather than joint number alone. Initial anchoring persists under time pressure.
What to do instead
Use a structured JIA worksheet at every visit: onset age, symptom duration, joint count now and at 6 months, fever pattern, rash, enthesitis, dactylitis, psoriasis, IBD symptoms, RF and ANA. Record a provisional subtype only after each criterion is explicitly checked.
Treating a positive ANA as sufficient to diagnose SLE and starting immunosuppression without applying classification criteria or documenting alternative explanations.
ANA is common in healthy children and in infections, autoimmune thyroid disease, and other connective tissue diseases; low-titer results are nonspecific, and candidates over-weight a single abnormal number.
What to do instead
Require ANA at a meaningful titer plus weighted clinical and immunologic domains from the EULAR/ACR classification criteria; explicitly list and exclude alternative diagnoses such as viral infection, drug reaction, and other CTD before labeling SLE.
Starting methotrexate or a biologic without a drug-specific baseline assessment and monitoring plan, including TB screening, hepatitis B status, CBC, liver enzymes, and varicella immunity.
Attention is drawn to the acute arthritis and to choosing the agent, while toxicity surveillance feels administrative and is easily deferred; latent TB and hepatitis reactivation are rare but consequential.
What to do instead
Before prescribing, complete a written checklist for that agent: latent TB testing before anti-TNF therapy, hepatitis B serologies, baseline CBC and liver enzymes for methotrexate, varicella immunity, and a scheduled lab monitoring calendar with explicit follow-up responsibility.
Labeling recurrent fevers as JIA or as repeated viral illnesses without recording the fever periodicity, duration, associated symptoms, and family history.
PFAPA, FMF, TRAPS, and CAPS have distinctive clocks and accompanying features, but busy visits reward the quick label; without a diary, the pattern is invisible.
What to do instead
Ask the family to keep a fever diary and use a syndrome-specific checklist: aphthous stomatitis, pharyngitis, and adenitis for PFAPA; serositis or erysipelas-like rash for FMF; cold-triggered symptoms for CAPS; and family history and ethnicity for hereditary fevers. Refer for genetic testing when indicated.
Dismissing Kawasaki disease because the child does not meet all classic criteria or because fever is attributed to a concurrent infection.
Incomplete Kawasaki disease is common, especially in infants, and a positive respiratory viral test does not exclude it; candidates count features rather than applying the incomplete-disease algorithm.
What to do instead
For fever lasting 5 days or more, apply the AHA algorithm: obtain CRP or ESR, CBC, platelet count, albumin, ALT, and urinalysis; if criteria are incomplete but laboratory markers are suggestive, obtain echocardiography and consider IVIG rather than waiting for every classic sign.
Escalating immunomodulatory therapy for presumed chronic arthritis in a child whose pain is amplified or whose joints are hypermobile, without first excluding non-inflammatory causes.
Amplified musculoskeletal pain can produce guarding, allodynia, and functional disability that mimic synovitis, and an earlier arthritis label tends to stick; clinicians fear missing inflammation and add treatment rather than reassessing.
What to do instead
Perform a deliberate non-inflammatory assessment: check for allodynia, joint hypermobility using the Beighton score, sleep, school attendance, and function; confirm the absence of swelling and normal inflammatory markers and imaging; then shift to multidisciplinary rehabilitation rather than escalating immunosuppression.
Attributing a hot, swollen joint or new bone pain to a JIA flare without obtaining cultures, imaging, or arthrocentesis, or missing recurrent infections as a clue to immunodeficiency.
Fever and joint swelling overlap between infection and inflammation, and anchoring on the known rheumatologic diagnosis is cognitively efficient; recurrent sinopulmonary infections may be dismissed as ordinary childhood illness.
What to do instead
When septic arthritis is plausible, obtain arthrocentesis and cultures before antibiotics and image when osteomyelitis is suspected. For recurrent or unusual infections, obtain immunoglobulins, lymphocyte subsets, complement studies, and vaccine titers before attributing everything to the rheumatic disease.
Ordering ANA subserologies, RF, or anti-CCP indiscriminately and then treating low-positive results as diagnostic of rheumatic disease.
Low pretest probability produces false positives, and reflex panels are easy to order; candidates confuse an abnormal number with a disease and then chase it with more testing.
What to do instead
Order autoantibodies only when the history and examination suggest a specific diagnosis; interpret titers against age-appropriate reference ranges and pretest probability; avoid ANA reflex panels and repeat testing that does not change management.
Deferring transition planning and psychosocial assessment until late adolescence, focusing only on disease activity and laboratory values.
Clinic time is consumed by disease management, and transition and mental health are assumed to be someone else's responsibility; adherence, school, and mood problems then surface as crises.
What to do instead
Begin transition readiness assessment in early adolescence and revisit it annually: use a structured psychosocial interview, assess adherence and school function, screen for anxiety and depression, and create a written transition plan with a warm handoff to adult rheumatology.
Classifying a primary immunodeficiency as autoimmune disease because the child presents with cytopenias, arthritis, or a lupus-like picture, without screening for immune defects.
Immunodeficiency and autoimmunity overlap, and unusual infections, family history, or poor vaccine responses may be buried in the history; the autoimmune label explains the immediate presentation.
What to do instead
Screen for immunodeficiency when there are recurrent or unusual infections, failure to respond to vaccines, a family history, or autoimmune cytopenias: obtain immunoglobulins, lymphocyte subsets, complement studies, and specific antibody titers before finalizing an autoimmune diagnosis.